New Zealand’s Medsafe is removing surgical mesh products from the market that are used for urogynecological indications.
The move follows a similar action by Australia’s Therapeutic Goods Administration last month. Medsafe said it relied on Australia’s safety report in making its decision.
“As is also the case in Australia, Medsafe’s response is effectively a limit on the supply of mesh for the repair of pelvic organ prolapse and stress urinary incontinence rather than a limit on use of surgical mesh for other types of surgery,” the New Zealand agency said.
Medsafe also will require suppliers to provide safety information about their devices.